Volatile ride for Verve Therapeutics, Inc. stock price on Tuesday moving between $32.88 and $36.29
(Updated on Dec 07, 2021)
Sell candidate since 2021-11-12 Loss -25.96% PDF
The Verve Therapeutics, Inc. stock price gained 11.13% on the last trading day (Tuesday, 7th Dec 2021), rising from $32.16 to $35.74. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 10.37% from a day low at $32.88 to a day high of $36.29. The price has been going up and down for this period, and there has been a -7.24% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 210 thousand more shares were traded than the day before. In total, 530 thousand shares were bought and sold for approximately $18.96 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -33.38% during the next 3 months and, with a 90% probability hold a price between $20.75 and $33.19 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 11.90%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Verve Therapeutics, Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $43.21. On a fall, the stock will find some support from the short-term average at $33.35. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss
Verve Therapeutics, Inc. finds support from accumulated volume at $35.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $3.41 between high and low, or 10.37%. For the last week, the stock has had a daily average volatility of 10.20%.
Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.
Is Verve Therapeutics, Inc. stock A Buy?
Verve Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.263
Predicted Opening Price for Verve Therapeutics, Inc. of Wednesday, December 8, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price December 8, 2021||Current price|
Remember To Visit Our YouTube Channel
On Sep 23, 2021 "Stifel Nicolaus" gave "" rating for VERV. The price target was set to $51.94+10.5%.
VERV Insider Trading
|Dec 02, 2021||Buy||4 700||Adelman Burt A||Common Stock|
|Dec 02, 2021||Buy||4 000||Ashe Andrew D.||Common Stock|
|Nov 29, 2021||Buy||7 500||Dorval Allison||Restricted Stock Units|
|Nov 29, 2021||Buy||135 000||Dorval Allison||Stock Option (right to buy)|
|Jun 21, 2021||Sell||4 104 416||Yeshwant Krishna||Series B Preferred Stock|
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.